The Cyr61 expression was correlated with cell migratory potential in osteosarcoma cells, and its upregulation promotes EMT and tumor metastasis in vivo. Moreover, the Cyr61-promoted mesenchymal transition was mediated by the integrin αvβ5, Raf-1, MEK, ERK, and Elk-1 signaling pathways. This evidence concerns the gene MAP2K7 and neoplasm.